Bradykinin-mediated angioedema (C1-INH)

Bradykinin-mediated angioedema (C1-INH)

Virtual assistant designed to support allergists/clinical immunologists, emergency physicians, anesthesiologists, intensivists, otolaryngologists, pediatricians, internists, and nursing staff in the initial assessment, diagnosis, stabilization, and management of bradykinin-mediated angioedema, including hereditary angioedema due to C1-INH deficiency/dysfunction (HAE types I/II and HAE-nC1-INH where applicable), acquired C1-INH–related angioedema, and ACE inhibitor/ARB–induced angioedema, in accordance with current guidelines and evidence.

Content automatically generated by an artificial intelligence system.It may contain inaccuracies.